Murphy Analytics Announces Initiation of Coverage on Axxess Pharma Inc.
November 05 2013 - 6:00PM
Access Wire
St. Louis, Missouri - November 5, 2013. Murphy
Analytics (MA) has initiated coverage on Axxess Pharma Inc.
(PinkSheets: AXXE). The Initiation Report contains a detailed
discussion of AXXE's planned business operations, market dynamics,
financials, potential cash flows, and risks. The Initiation
Report is available
at: http://www.murphyanalytics.com/uploads/AXXE_Initiation.pdf.
Axxess is a specialty Health Care Products Company dedicated to
improving health and quality of life by offering select medicines,
nutritional supplements and over the counter remedies all across
the Americas. Axxess's goal is to bring additional products to the
market and provide new, innovative options for better health
spanning areas such as high cholesterol, blood pressure, acute
pain, to optimal health management through improved nutritional
supplements. Analyst Patrick Murphy notes in the
report: "...with a recently announced line of credit
term sheet, AXXE is demonstrating further progress in developing a
model to capitalize on highly attractive market opportunities."
About Murphy Analytics
Murphy Analytics is an investment research firm providing
coverage of microcap stocks. Utilizing institutional caliber,
fundamental analysis, Murphy Analytics helps readers become more
informed about equities without extensive analyst coverage. Murphy
Analytics LLC is owned by Patrick J. Murphy, who has nearly 20
years of capital markets experience, providing institutional
investment and transaction analysis across a range of asset classes
including microcap equities, commercial real estate debt and
equity, municipal derivatives and public finance, venture
capital, fixed income, CMBS and mortgage REIT's.
Contact:
Patrick J. Murphy, CFA
pmurphy@murphyanalytics.com
Disclosure: MA was paid $5,000 by the Company in advance
of the publication of this report. Neither MA nor the analyst owns
or trades the shares of covered companies. Statements herein
may contain forward-looking statements and are subject to
significant risks and uncertainties affecting results. MA provides
no assurance as to the subject company's plans or ability to effect
proposed actions and cannot project capabilities, intent,
resources, or experience. This report is neither a
solicitation to buy nor an offer to sell securities and is to be
used for informational purposes only and should not be used as
basis for investment decisions. MA is not an investment advisor or
broker/dealer and this report does not provide investment
advice.
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2024 to Aug 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Aug 2023 to Aug 2024